Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| West Virginia University | OTHER |
| Rush University | OTHER |
| Asian Institute of Gastroenterology, India | OTHER |
| Medanta, The Medicity, India |
Not provided
Not provided
Not provided
Malignant gastric outlet obstruction (GOO) results from the mechanical obstruction of the duodenum or distal stomach from an underlying cancer. The aim of this study is to compare the clinical outcomes between surgical gastrojejunostomy and EUS-guided gastrojejunostomy in patients with malignant gastric outlet obstruction.
Malignant gastric outlet obstruction (GOO) results from the mechanical obstruction of the duodenum or distal stomach from an underlying cancer. The consequences of GOO are abdominal pain, nausea, vomiting, anorexia, inability to maintain an oral diet and weight loss, with associated poor quality of life and inability to continue with cancer therapy. The aim of this study is to compare the clinical outcomes between surgical gastrojejunostomy and EUS-guided gastrojejunostomy in patients with malignant gastric outlet obstruction.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| EUS-guided gastrojejunostomy | Active Comparator | EUS-guided gastrojejunostomy is performed using a lumen-apposing metal stent |
|
| Surgical gastrojejunostomy | Active Comparator | A surgical gastrojejunostomy will be created via laparoscopic or robotic techniques (preferred) or open technique (if these methods fail), as clinically appropriate. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| EUS-guided gastrojejunostomy | Procedure | AXIOS lumen-apposing metal stent will be used to create a gastrojejunostomy under EUS guidance. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Composite end point of inability to tolerate a solid diet (defined as gastric outlet obstruction scoring system score <2) or requiring additional interventions or supplemental nutrition or procedure-related adverse events. | Proportion of patients unable to tolerate a solid diet at time of hospital discharge (defined as gastric outlet obstruction scoring system score <2) or requiring additional interventions or supplemental nutrition or procedure-related adverse events. | 6 months |
| Measure | Description | Time Frame |
|---|---|---|
| Gastric Outlet Obstruction Scoring System (GOOSS) score of ≥ 2 at 1-month post-procedure, without the need for repeat intervention or supplemental nutrition such as the use of enteric feeding tubes or total parenteral nutrition (TPN). | Proportion of patients with Gastric Outlet Obstruction Scoring System (GOOSS) score of ≥ 2 at 1-month post-procedure, without the need for repeat intervention or supplemental nutrition such as the use of enteric feeding tubes or total parenteral nutrition (TPN). |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Ji Young Bang, MD MPH | Orlando Health | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Orlando Health | Orlando | Florida | 32806 | United States |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 40998416 | Derived | Bang JY, Puri R, Lakhtakia S, Thakkar S, Waxman I, Siddiqui I, Arnold K, Chaudhary A, Mehta S, Singh A, Venkat Rao G, Basha J, Gupta R, Modak S, Singh S, Boone B, Dautel P, Dixon MEB, Kim HM, Sutton B, Arnoletti JP, Rosch T, Varadarajulu S. Endoscopic or surgical gastroenterostomy for malignant gastric outlet obstruction: a randomised trial. Gut. 2025 Dec 5;75(1):24-32. doi: 10.1136/gutjnl-2025-336339. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D017219 | Gastric Outlet Obstruction |
| D009369 | Neoplasms |
| ID | Term |
|---|---|
| D013272 | Stomach Diseases |
| D005767 | Gastrointestinal Diseases |
| D004066 | Digestive System Diseases |
Not provided
Not provided
| OTHER |
| University of Hamburg-Eppendorf | OTHER |
Not provided
Not provided
Not provided
Not provided
| Surgical gastrojejunostomy | Procedure | A surgical gastrojejunostomy will be created via laparoscopic or robotic techniques (preferred) or open technique (if these methods fail), as clinically appropriate. |
|
| 6 months |
| Gastric Outlet Obstruction Scoring System (GOOSS) score of ≥ 2 at 6-month post-procedure, without the need for repeat intervention or supplemental nutrition such as the use of enteric feeding tubes or total parenteral nutrition (TPN). | Proportion of patients with Gastric Outlet Obstruction Scoring System (GOOSS) score of ≥ 2 at 6-month post-procedure, without the need for repeat intervention or supplemental nutrition such as the use of enteric feeding tubes or total parenteral nutrition (TPN). | 6 months |
| Rate of technical success | Technical success is defined as the successful creation of a gastrojejunal anastomosis by the originally assigned method. | 24 hours |
| Procedure duration | Procedure duration for EUS-guided and surgical gastrojejunostomy procedures | 24 hours |
| Time to diet advancement | Time to liquid diet (GOOSS score 1), soft solid diet (GOOSS score 2) and regular solid diet (GOOSS score 3). | 1 month |
| Time to recurrence of obstructive symptoms | Recurrence of obstructive symptoms, defined as the recurrence of obstructive symptoms (GOOSS score ≤ 1) after achieving GOOSS ≥ 2 for at least 7 days at any time during follow-up. | 6 months |
| Rate of persistence of symptoms | Persistent of obstructive symptoms, defined as continuing symptoms up to 2 weeks after index procedure. | 6 months |
| Rate of reintervention | Reintervention, defined as need for repeat treatment for persistent or recurrent obstructive symptoms. Reintervention can be any endoscopic or surgical therapy. | 6 months |
| Total number of readmissions | Total no. of readmissions due to disease-related symptoms or procedure-related events. | 6 months |
| Rate of adverse events due to procedures performed | Procedure-related adverse events | 6 months |
| Rate of adverse events due to underlying disease | Disease-related adverse events | 6 months |
| Total length of hospital stay | Duration of hospitalization, defined as the length of hospital stay from the date of the procedure to the date of discharge. | 6 months |
| Length of survival | Duration of survival post-procedure. | 6 months |
| Time to initiation of chemotherapy post-procedure | Time to initiation of chemotherapy post-procedure | 6 months |
| Quality of life measurement | Quality of life post-procedure as determined by the EORTC-QLQ-C30 quality of life questionnaire. | 6 months |
| Treatment costs | All relevant costs pertaining to treatment of gastric outlet obstruction will be taken into consideration from index intervention to hospital discharge: procedure costs, inpatient hospital stay from date of procedure to discharge, medications, materials, anesthesia, pharmacy and imaging studies. | 6 months |